IP Library Assignment 054960/0348
Patent Assignment
Reel/Frame 054960/0348

Change of Name

Recorded: 2021-01-11 Pages: 4
Assignor
SEATTLE GENETICS, INC.
Executed: 2020-10-06
Assignee
SEAGEN INC.
21823 30TH DRIVE SE, BOTHELL, WASHINGTON, 98021
Covered Properties (31)
Pentapeptide Compounds and Uses Related Thereto
Patent: 6,884,869 →
Application: 10/001,191 →
Publication: US 2005/0009751
Pentapeptide Compounds and Uses Related Thereto
Patent: 7,256,257 →
Application: 10/476,391 →
Publication: US 2004/0157782
Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders
Patent: 7,662,387 →
Application: 10/546,304 →
Publication: US 2006/0233794
Pentapeptide Compounds and Uses Related Thereto
Patent: 7,098,308 →
Application: 10/979,923 →
Publication: US 2005/0113308
Monomethylvaline Compounds Capable of Conjugation to Ligands
Patent: 7,498,298 →
Application: 10/983,340 →
Publication: US 2005/0238649
Anti-CD70 Antibody and Its Use for the Treatment and Prevention of Cancer and Immune Disorders
Patent: 7,491,390 →
Application: 11/251,173 →
Publication: US 2006/0083736
Pentapeptide Compounds and Uses Related Thereto
Patent: 7,423,116 →
Application: 11/451,147 →
Publication: US 2006/0229253
Anti-CD70 Antibody and Its Use for the Treatment and Prevention of Cancer and Immune Disorders
Patent: 7,641,903 →
Application: 11/735,365 →
Publication: US 2007/0292422
Monomethylvaline Compounds Capable of Conjugation to Ligands
Patent: 7,994,135 →
Application: 11/833,954 →
Publication: US 2009/0047296
Monomethylvaline Compounds Capable of Conjugation to Ligands
Patent: 7,964,566 →
Application: 11/833,959 →
Publication: US 2008/0248053
Monomethylvaline Compounds Capable of Conjugation to Ligands
Patent: 7,964,567 →
Application: 11/833,961 →
Publication: US 2008/0248051
Monomethylvaline Compounds Capable of Conjugation to Ligands
Patent: 7,745,394 →
Application: 11/833,964 →
Publication: US 2008/0226657
Humanized Anti-CD70 Binding Agents and Uses Thereof
Patent: 8,067,546 →
Application: 11/912,096 →
Publication: US 2009/0148942
Humanized Anti-CD40 Antibodies and Their Methods of Use
Patent: 8,303,955 →
Application: 11/913,305 →
Publication: US 2009/0181015
Treatment of Immune Disorders with Anti-CD70 Antibody
Patent: 8,647,624 →
Application: 12/016,814 →
Publication: US 2008/0138341
Anti-CD70 Antibody and Its Use for the Treatment of Cancer and Immune Disorders
Patent: 9,051,372 →
Application: 12/265,451 →
Publication: US 2009/0074772
Anti-CD70 Antibody and Its Use for the Treatment and Prevention of Cancer and Immune Disorders
Patent: 8,337,838 →
Application: 12/370,151 →
Publication: US 2009/0232806
Treatment of Renal Cell Carcinoma with Anti-CD70 Antibody-Drug Conjugates
Patent: 9,345,785 →
Application: 12/635,607 →
Publication: US 2010/0158910
Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment and Prevention of Cancer and Immune Disorders
Patent: 8,663,642 →
Application: 12/891,716 →
Publication: US 2011/0150908
Detection and Treatment of Pancreatic, Ovarian and Other Cancers
Patent: 9,120,854 →
Application: 12/937,190 →
Publication: US 2011/0300131
Monomethylvaline Compounds Capable of Conjugation to Ligands
Patent: 8,703,714 →
Application: 13/098,391 →
Publication: US 2012/0003247
Monomethylvaline Compounds Capable of Conjugation to Ligands
Patent: 8,557,780 →
Application: 13/098,393 →
Publication: US 2012/0003248
Humanized Anti-CD70 Binding Agents and Uses Thereof
Patent: 8,562,987 →
Application: 13/271,143 →
Publication: US 2012/0045436
Anti-CD70 Antibody-Drug Conjugates and Their Use for the Treatment of Cancer and Immune Disorders
Patent: 8,535,678 →
Application: 13/485,536 →
Publication: US 2012/0288512
Treatment of B-Cell Cancers with Anti-CD70 Antibody-Drug Conjugates
Patent: 8,609,104 →
Application: 13/491,475 →
Publication: US 2012/0251559
Nucleic Acids Encoding Humanized Anti-CD40 Antibodies
Patent: 8,492,531 →
Application: 13/622,517 →
Publication: US 2013/0023047
Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
Patent: 9,228,026 →
Application: 13/990,778 →
Publication: US 2013/0259860
Humanized Anti-CD70 Binding Agents and Uses Thereof
Patent: 9,428,585 →
Application: 14/053,164 →
Publication: US 2014/0178936
Humanized Antibodies To LIV-1 And Use Of Same To Treat Cancer
Patent: 9,783,608 →
Application: 14/948,183 →
Publication: US 2016/0185858
Humanized Anti-CD70 Binding Agents and Uses Thereof
Patent: 9,701,752 →
Application: 15/217,109 →
Publication: US 2017/0022282
Monomethylvaline Compounds Capable of Conjugation to Ligands
Application: 15/811,190 →
Publication: US 2018/0127512
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 15, 2002
From: DORONINA, SVETLANA; SENTER, PETER D.; TOKI, BRIAN E.
To: SEATTLE GENETICS, INC.
Reel/Frame 012711/0472 →
Assignment of Assignor's Interest Mar 29, 2004
From: DORONINA, SVETLANA; SENTER, PETER D.; TOKI, BRIAN E.
To: SEATTLE GENETICS, INC.
Reel/Frame 015157/0645 →
Assignment of Assignor's Interest Dec 15, 2004
From: DORONINA, SVETLANA O.; SENTER, PETER D.; TOKI, BRIAN E.
To: SEATTLE GENETICS, INC.
Reel/Frame 015458/0247 →
Assignment of Assignor's Interest Jan 27, 2005
From: GENETECH, INC.; EBENS, ALLEN J.; POLAKIS, PAUL; SPENCER, SUSAN D.
To: SEATTLE GENETICS, INC.; GENENTECH, INC.
Reel/Frame 016210/0504 →
Assignment of Assignor's Interest May 17, 2005
From: EBENS, ALLEN J.; POLAKIS, PAUL; SLIWKOWSKI, MARK X.; SPENCER, SUSAN D.
To: GENENTECH, INC.
Reel/Frame 016025/0390 →
Assignment of Assignor's Interest May 17, 2005
From: GENENTECH, INC.
To: SEATTLE GENETICS, INC.
Reel/Frame 016025/0400 →
Assignment of Assignor's Interest Dec 1, 2005
From: DORONINA, SVETLANA O.; SENTER, PETER D.; TOKI, BRIAN E.; KLINE, TONI BETH
To: SEATTLE GENETICS, INC.
Reel/Frame 017081/0910 →
Assignment of Assignor's Interest Dec 21, 2005
From: LAW, CHE-LEUNG; MCEARCHERN, JULIE; WAHL, ALAN F.
To: SEATTLE GENETICS, INC.
Reel/Frame 016928/0453 →
Assignment of Assignor's Interest Feb 3, 2006
From: LAW, CHE-LEUNG; PESTANO, LINDA A.; WAHL, ALAN F.; SCHOLLER, NATHALIE
To: SEATTLE GENETICS
Reel/Frame 017119/0279 →
Assignment of Assignor's Interest Feb 17, 2006
From: EBENS, ALLEN J.; POLAKIS, PAUL; SLIWKOWSKI, MARK X.; SPENCER, SUSAN D.
To: GENENTECH, INC.
Reel/Frame 017270/0587 →
Assignment of Assignor's Interest Aug 13, 2007
From: LAW, CHE-LEUNG; MCEARCHERN, JULIE; WAHL, ALAN F.
To: SEATTLE GENETICS, INC.
Reel/Frame 019687/0066 →
Assignment of Assignor's Interest Nov 7, 2008
From: LAW, CHE-LEUNG; MCEARCHERN, JULIE; WAHL, ALAN F.
To: SEATTLE GENETICS, INC.
Reel/Frame 021803/0079 →
Assignment of Assignor's Interest Feb 19, 2009
From: LAW, CHE-LEUNG; MCEARCHERN, JULIE; WAHL, ALAN F.
To: SEATTLE GENETICS
Reel/Frame 022282/0098 →
Assignment of Assignor's Interest May 7, 2010
From: PRESTA, LEONARD G.; O'CONNELL, LORI Y.
To: GENENTECH, INC.
Reel/Frame 024356/0004 →
Assignment of Assignor's Interest May 2, 2013
From: SEATTLE GENETICS, INC.
To: GENENTECH, INC.
Reel/Frame 030342/0086 →
Assignment of Assignor's Interest Jan 2, 2020
From: DORONINA, SVETLANA O.; SENTER, PETER D.; TOKI, BRIAN E.; KLINE, TONI BETH
To: SEATTLE GENETICS, INC.
Reel/Frame 051399/0348 →
Assignment of Assignor's Interest Jan 2, 2020
From: GENENTECH, INC.
To: SEATTLE GENETICS, INC.
Reel/Frame 051399/0725 →
Assignment of Assignor's Interest Jan 2, 2020
From: EBENS, ALLEN J.; POLAKIS, PAUL =; SLIWKOWSKI, MARK X.; SPENCER, SUSAN D.
To: GENENTECH, INC.
Reel/Frame 051399/0712 →
Assignment of Assignor's Interest Jan 2, 2020
From: DORONINA, SVETLANA O.; SENTER, PETER D.; TOKI, BRIAN E.; KLINE, TONI BETH
To: SEATTLE GENETICS INC.
Reel/Frame 051399/0654 →
Assignment of Assignor's Interest Jan 2, 2020
From: GENENTECH, INC.
To: SEATTLE GENETICS, INC.
Reel/Frame 051399/0436 →
Assignment of Assignor's Interest Jan 2, 2020
From: EBENS, ALLEN J.; POLAKIS, PAUL; SLIWKOWSKI, MARK X.; SPENCER, SUSAN D.
To: GENENTECH, INC.
Reel/Frame 051399/0422 →
Assignment of Assignor's Interest Jan 8, 2020
From: GENENTECH, INC.
To: SEATTLE GENETICS, INC.
Reel/Frame 051447/0001 →
Assignment of Assignor's Interest Jan 8, 2020
From: DORONINA, SVETLANA O.; SENTER, PETER D.; TOKI, BRIAN E.; KLINE, TONI BETH
To: SEATTLE GENETICS, INC.
Reel/Frame 051445/0991 →
Assignment of Assignor's Interest Jan 8, 2020
From: GENENTECH, INC.
To: SEATTLE GENETICS, INC.
Reel/Frame 051446/0093 →
Assignment of Assignor's Interest Jan 8, 2020
From: EBENS, ALLEN J.; POLAKIS, PAUL; SLIWKOWSKI, MARK X.; SPENCER, SUSAN D.
To: GENENTECH, INC.
Reel/Frame 051446/0063 →